AU2600100A - Methods and compositions for delivering nucleic acids - Google Patents

Methods and compositions for delivering nucleic acids

Info

Publication number
AU2600100A
AU2600100A AU26001/00A AU2600100A AU2600100A AU 2600100 A AU2600100 A AU 2600100A AU 26001/00 A AU26001/00 A AU 26001/00A AU 2600100 A AU2600100 A AU 2600100A AU 2600100 A AU2600100 A AU 2600100A
Authority
AU
Australia
Prior art keywords
compositions
methods
nucleic acids
delivering nucleic
delivering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26001/00A
Inventor
Jinkang Wang
Todd Wedeking
Yi-Lin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urigen Pharmaceuticals Inc
Original Assignee
Urigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urigen Pharmaceuticals Inc filed Critical Urigen Pharmaceuticals Inc
Publication of AU2600100A publication Critical patent/AU2600100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
AU26001/00A 1999-01-05 2000-01-05 Methods and compositions for delivering nucleic acids Abandoned AU2600100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11474899P 1999-01-05 1999-01-05
US60114748 1999-01-05
PCT/US2000/000181 WO2000040692A2 (en) 1999-01-05 2000-01-05 Methods and compositions for delivering nucleic acids

Publications (1)

Publication Number Publication Date
AU2600100A true AU2600100A (en) 2000-07-24

Family

ID=22357192

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26001/00A Abandoned AU2600100A (en) 1999-01-05 2000-01-05 Methods and compositions for delivering nucleic acids

Country Status (2)

Country Link
AU (1) AU2600100A (en)
WO (1) WO2000040692A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010046705A1 (en) * 2000-04-25 2001-11-29 Arnaud Debin Particulate complex for adminstering nucleic acid into a cell
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
EP1389182A1 (en) * 2001-05-15 2004-02-18 Transgene S.A. Complexes for transferring substances of interest into a cell
JP4629333B2 (en) * 2001-08-29 2011-02-09 アベンティス・ファーマ・ソシエテ・アノニム Lipid derivatives of aminoglycosides
FR2829136B1 (en) * 2001-08-29 2006-11-17 Aventis Pharma Sa LIPID DERIVATIVES OF AMINOGLYCOSIDES
JP5407862B2 (en) * 2006-10-04 2014-02-05 サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク（セーエヌエールエス） Composition comprising siRNA and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivative and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400375A (en) * 1981-11-23 1983-08-23 Eli Lilly And Company Tobramycin-double stranded RNA complex suitable for inducing interferon
US6113946A (en) * 1992-04-03 2000-09-05 The Regents Of The University Of California Self-assembling polynucleotide delivery system comprising dendrimer polycations

Also Published As

Publication number Publication date
WO2000040692A3 (en) 2008-02-28
WO2000040692A9 (en) 2001-06-07
WO2000040692A2 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
AU2625501A (en) Compositions and methods for gene silencing
AU9692198A (en) Gene delivery compositions and methods
AU4193700A (en) Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
AUPQ419099A0 (en) Novel compositions and methods
AU3719500A (en) Recombination of insertion modified nucleic acids
AU2001285143A1 (en) Methods and compositions for targeted delivery
AU2001280968A1 (en) Compositions and methods for directed gene assembly
EP1165586A4 (en) TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001245987A1 (en) Compositions and methods for gene therapy
AU5565099A (en) Pharmaceutical compositions and methods for use
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU6611500A (en) Single-phase amplification of nucleic acids
AU2001238485A1 (en) Methods and compositions for gene delivery
ZA979295B (en) Methods and compositions for delivery and expression of interferon-Ó nucleic acids.
AU7474100A (en) Methods and compositions for reducing immune response
EP1080225A4 (en) Compositions and methods for the pulmonary delivery of nucleic acids
AU2405900A (en) Methods and products for delivering nucleic acids
AU2970299A (en) Compositions and methods for polynucleotide delivery
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2600100A (en) Methods and compositions for delivering nucleic acids
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
EP1163340A4 (en) Compositions and methods for the modification of gene expression
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU3926000A (en) Methods and compositions for drug delivery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase